CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Wuhan Easy Diagnosis Biomedicine Co Ltd is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Wuhan Easy Diagnosis Biomedicine Co Ltd
2F, Building E,Students Pioneering Park
Special No. 1 Dongxin Road
Phone: +86 2787001772p:+86 2787001772 WUHAN, HUB  430075  China Ticker: 002932002932
Business Summary
Wuhan Easy Diagnosis Biomedicine Co Ltd is a China-based company primarily engaged in pharmaceutical manufacturing. The Company’s core businesses include research and development, production, sales, and service of in vitro diagnostic reagents and instruments, the provision of information technology solutions for critical care, including information technology software products, supporting hardware, and certification consulting services, third-party medical testing services, and the development and production of health foods such as soft capsules and beverages. The Company also develops a distribution business, The Company primarily operating in domestic and overseas markets.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-----

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
6/30/202512/31/2024Yes----

Industries
SIC Code Description
2835 In vitro and in vivo diagnostic substances
3845 Electromedical and electrotherapeutic apparatus
8071 Medical laboratories
7389 Business services, not elsewhere classified
7372 Prepackaged software
2833 Medicinal chemicals and botanical products
2099 Food preparations, not elsewhere classified

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board, General Manager LiliChen 49 10/1/2013 10/1/2013
Vice Chairman of the Board, Deputy General Manager YingWang 49 10/1/2022 7/1/2008
Finance Director, Deputy General Manager, Secretary of the Board RuiWang 45 2/6/2024 7/1/2018
5 additional Officers and Directors records available in full report.

General Information
Number of Employees: 812 (As of 12/31/2024)
Outstanding Shares: 219,486,216 (As of 6/30/2025)
Shareholders: 27,371
Stock Exchange: SHE
Fax Number: +86 2765521900


Copyright © 2025 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Tuesday, September 9, 2025
Register now for our FAST Rating webinar on September 10 at 2:00 PM ET!